Nucleosides activate SIRT1 and suppress the NF-κB/p65 pathway while also reducing TGF-β1/Smad signaling and increasing Smad7 expression, thereby attenuating airway inflammation and fibrosis in RAW264.7 macrophages and mice with COPD [66]. Here, NFKB1 is linked to chronic obstructive pulmonary disease.